(NYSE:ETD), DANBURY, CT, Oct. 29, 2025 (GLOBE NEWSWIRE) — Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETD), a leading interior design destination, today reported its results for the fiscal 2026 first quarter ended September 30, 2025. Farooq Kathwari, Ethan Allen's Chairman, President and CEO commented, “Despite many macroeconomic challenges, we were pleased […]

(NYSE:TNK), HAMILTON, Bermuda, Oct. 29, 2025 (GLOBE NEWSWIRE) — Teekay Tankers Ltd. (Teekay Tankers or the Company) (NYSE: TNK) today reported the Company's results for the quarter ended September 30, 2025 and announced that its Board of Directors has declared its fixed cash dividend of $0.25 per share for the quarter ended September 30, 2025.

(NYSE:TK),(NYSE:TNK), HAMILTON, Bermuda, Oct. 29, 2025 (GLOBE NEWSWIRE) — Teekay Corporation Ltd. (Teekay or the Company) (NYSE:TK) today reported an update for the three months ended September 30, 2025. The update and Teekay Group's earnings presentation are available on the Company's website here. About Teekay Teekay is a leading provider of international crude oil marine

(NASDAQ:AMRX), BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's Abbreviated New Drug Application (ANDA) for beclomethasone dipropionate HFA inhalation aerosol (40 mcg/actuation and 80 mcg/actuation). The product is the generic equivalent of QVAR(R)

(NASDAQ:SHEN), EDINBURG, Va., Oct. 29, 2025 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced third quarter 2025 financial and operating results. Third Quarter 2025 Highlights Glo Fiber Expansion Markets revenue grew 41.1% compared to the third quarter of 2024 to $21.3 million due to a 41.3% increase in average subscribers.

(NASDAQ:GCTK), RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Usman Latif, MD, MBA, has been named to Glucotrack's clinical advisory team, providing strategic counsel as the Company

(NASDAQ:ABSI), VANCOUVER, Wash. and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2025 after market close on Wednesday, November 12, 2025. Absci management will webcast

(NASDAQ:AMRK), EL SEGUNDO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, maintaining the company's current dividend program. The dividend is payable on December 2, 2025

(NASDAQ:HWKN), ROSEVILLE, Minn., Oct. 29, 2025 (GLOBE NEWSWIRE) — At its recent board meeting, the Board of Directors of Hawkins, Inc. (Nasdaq: HWKN) declared a quarterly cash dividend of $0.19 per share, payable November 28, 2025, to shareholders of record at the close of business on November 14, 2025. Hawkins has consistently paid out a

(NASDAQ:SEER), REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced company management will be participating in the following investor conferences: UBS Global Healthcare Conference in Palm Beach Gardens, FLHosting 1×1 meetings on Wednesday, November 12th Canaccord Genuity MedTech, Diagnostics